Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
Imaging device, method and computer readable medium
Cycloalkylamine substituted isoquinoline derivatives
Diagnostic data interchange
Adding value to a rendered document
Medical diagnosis, therapy, and prognosis system for invoked events and methods thereof
Vaccine composition against Streptococcus pyogenes
  Randomly Featured Patents
Petunia plant named `KEIreom`
Metal vapor lamp starting and operating apparatus
Variable speed wind turbine generator with zero-sequence filter
Process and devices for hardening of glassware by ion exchange
Image forming apparatus, launching method of program in the apparatus, image forming system, and program and storage medium therefor
Transfer apparatus for chemical reaction pack
Resin-coated seamless can
Semiconductor device
Apparatus and method for determining uplink ciphering activation time in universal mobile telecommunications system user equipment
Steam generator assembly for pressurized water reactors with a straight tube bundle and a partial flow preheater traversible by pressurized water